H. Lee

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

Joy N. Tsai, Alexander V. Uihlein, Sherri‐Ann M. Burnett‐Bowie et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 120 citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16

DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer

D-W Wu, M-C Lee, Jiaan‐Der Wang et al. · Oncogene · 2013 · 94 citations

Medicine, Cell Biology, Oncology +17

Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

Ing‐Lin Chang, Tsay-I Chiang, Ken-Tu Yeh et al. · Osteoporosis International · 2010 · 92 citations

Medicine, Endocrinology, Gynecology +16

The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss

L-H Tsai, J-Y Wu, Y-W Cheng et al. · Oncogene · 2014 · 81 citations

Medicine, Genetics, Oncology +16

c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT

D-W Wu, N-Y Hsu, Y-C Wang et al. · Oncogene · 2014 · 81 citations

Medicine, Cancer Biology, Oncology +17